Physician profile
Ashit Patel
NPI 1093987828
$6,295.67
in general payments reported to CMS, 2019-2025
13 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $1,713 · 2021: $986 · 2022: $513 · 2023: $1,019 · 2024: $805 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,297.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,726.02 | 2023-2025 | |
| Abbott Laboratories | $1,520.00 | 2020 | |
| Sientra, INC. | $1,001.55 | 2019-2022 | |
| Allergan, INC. | $702.95 | 2019-2022 | |
| Davol INC. | $372.49 | 2022-2023 | Phasix Mesh, Arista Ah Flexitip |
| Musculoskeletal Transplant Foundation INC. | $192.63 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $164.38 | 2021 | |
| Tela Bio, INC. | $153.70 | 2021-2022 | |
| Acell, INC. | $138.50 | 2019 | |
| Acera Surgical, INC. | $124.79 | 2023 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $107.41 | 2022-2023 | Integra, Omnigraft, Surgimend |
| Stryker Corporation | $78.01 | 2019-2021 | |
| Convatec INC. | $13.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.